Morimoto et al., 2021 - Google Patents
SLPI is a critical mediator that controls PTH-induced bone formationMorimoto et al., 2021
View HTML- Document ID
- 14181148747771378434
- Author
- Morimoto A
- Kikuta J
- Nishikawa K
- Sudo T
- Uenaka M
- Furuya M
- Hasegawa T
- Hashimoto K
- Tsukazaki H
- Seno S
- Nakamura A
- Okuzaki D
- Sugihara F
- Ninomiya A
- Yoshimura T
- Takao-Kawabata R
- Matsuda H
- Ishii M
- Publication year
- Publication venue
- Nature Communications
External Links
Snippet
Osteoclastic bone resorption and osteoblastic bone formation/replenishment are closely coupled in bone metabolism. Anabolic parathyroid hormone (PTH), which is commonly used for treating osteoporosis, shifts the balance from osteoclastic to osteoblastic, although it is …
- 101700035022 SLPI 0 title abstract description 114
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Morimoto et al. | SLPI is a critical mediator that controls PTH-induced bone formation | |
Wu et al. | TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models | |
Correia et al. | Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy | |
Yu et al. | TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription | |
Lu et al. | Eosinophil extracellular traps drive asthma progression through neuro-immune signals | |
Ma et al. | Circulating miR-181c-5p and miR-497-5p are potential biomarkers for prognosis and diagnosis of osteoporosis | |
Giuliani et al. | Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation | |
Schloesser et al. | Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis | |
Li et al. | Hsa_circ_0045714 regulates chondrocyte proliferation, apoptosis and extracellular matrix synthesis by promoting the expression of miR-193b target gene IGF1R | |
Furuta et al. | IL-25 causes apoptosis of IL-25R–expressing breast cancer cells without toxicity to nonmalignant cells | |
Nyström et al. | Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa | |
Kondo et al. | IL-17 inhibits chondrogenic differentiation of human mesenchymal stem cells | |
Wu et al. | SCUBE2 mediates bone metastasis of luminal breast cancer by modulating immune-suppressive osteoblastic niches | |
Wang et al. | CD147 promotes collective invasion through cathepsin B in hepatocellular carcinoma | |
Infante et al. | Secretome analysis of in vitro aged human mesenchymal stem cells reveals IGFBP7 as a putative factor for promoting osteogenesis | |
Park et al. | FAM19A5, a brain-specific chemokine, inhibits RANKL-induced osteoclast formation through formyl peptide receptor 2 | |
Islam et al. | Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC‐STAMP | |
Zhang et al. | Knockdown of hsa_circ_0134111 alleviates the symptom of osteoarthritis via sponging microRNA-224-5p | |
Parodi et al. | Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment | |
Huang et al. | Calpastatin prevents NF-κB–mediated hyperactivation of macrophages and attenuates colitis | |
Rauschenberger et al. | T cells control chemokine secretion by keratinocytes | |
Yang et al. | CXCL2 attenuates osteoblast differentiation by inhibiting the ERK1/2 signaling pathway | |
Chen et al. | Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis | |
Pontejo et al. | Chemokines act as phosphatidylserine-bound “find-me” signals in apoptotic cell clearance | |
Murthy et al. | Danger signal extracellular calcium initiates differentiation of monocytes into SPP1/osteopontin-producing macrophages |